Trump administration cuts program that was developing a promising new HIV vaccine

For astir 15 years, Dennis Burton worked connected creating an HIV vaccine considered to beryllium 1 of nan starring vaccine efforts. In precocious May, he learned nan Trump management was ending nan project.

MICHEL MARTIN, HOST:

Immunologist Dennis Burton sewage immoderate bad news recently. On nan past Friday successful May, he learned that nan Trump management was going to extremity a task he'd co-led for astir 15 years. Its intent was to create a vaccine against AIDS.

DENNIS BURTON: It's devastating. It's very, very dispiriting. So overmuch effort, truthful overmuch quality toil has gone into this, and now that's conscionable going to beryllium thrown distant conscionable erstwhile we look for illustration we could hit this virus.

MARTIN: NPR's Jonathan Lambert picks up nan story.

JONATHAN LAMBERT, BYLINE: It wasn't conscionable Dennis Burton who was devastated. Many researchers successful nan section believed they were getting person than ever to processing a vaccine against AIDS aft astir 40 years of trying. Burton was portion of a $258 cardinal task called nan Center for HIV/AIDS Vaccine Development that's been astatine nan cutting separator of trying to lick a really difficult problem. Here's Burton again.

BURTON: It's 1 of nan astir difficult problems location is successful biomedicine. One of nan astir formidable things astir HIV is that it's not conscionable 1 virus, it's hundreds of thousands of different strains of virus.

LAMBERT: That makes HIV really bully astatine dodging nan immune system's first responders - antibodies. Burton and his colleagues astatine Scripps Research Institute, on pinch Duke University, were moving connected ways of coaxing nan immune strategy to make what are called broadly neutralizing antibodies.

BURTON: They're capable to admit different strains, and they're very potent.

LAMBERT: Animal studies propose this strategy could work, and quality tests were slated to commencement adjacent year, but now those tests apt won't happen.

Here's Mark Feinberg, CEO of IAVI, a nonprofit that develops vaccines.

MARK FEINBERG: It's really disappointing astatine this time, which is really much promising successful nan HIV vaccine effort than ever before, to person nan instauration kicked retired from underneath you.

LAMBERT: In a connection to NPR, a spokesperson for HHS says that they're trying to extremity what they telephone wasteful and inefficient spending. The Trump administration's cuts spell acold beyond conscionable 1 project.

Linda-Gail Bekker is pinch nan University of Cape Town. She was portion of a large USAID-funded task to create and trial HIV vaccine candidates successful Africa, including ones developed by Burton's grant. Just days earlier her squad was group to commencement objective trials, they sewage a extremity activity bid from nan U.S. government.

LINDA-GAIL BEKKER: So ill-timed and specified a tragedy. It felt for illustration nan stars were opening to align for nan field, again, after, you know, benignant of going done nan vale of despair of not having success.

LAMBERT: She and her colleagues are scrambling to find different sources of funding, but nan U.S. will beryllium reliable to replace. In 2022, it accounted for astir 90% of full HIV vaccine research-spending worldwide. In a ambiance of wide assistance cancellations and talk of complete 40% cuts to investigation backing adjacent year, galore scientists fearfulness caller advances will stall out.

BEKKER: We request each our power to triumph nan technological war, and now we person to conflict this turning distant from nan science, a existent disregard for nan request for an HIV vaccine.

LAMBERT: While effective treatments do beryllium for HIV, Bekker says that only a vaccine tin yet extremity nan pandemic. She believes nan section will yet get backmost connected track, but that will return time. Time, she says, that will costs galore lives that mightiness person been saved by a vaccine.

Jonathan Lambert, NPR News.

(SOUNDBITE OF YUME BITSU SONG, "I WAIT FOR YOU")

Copyright © 2025 NPR. All authorities reserved. Visit our website terms of use and permissions pages astatine www.npr.org for further information.

Accuracy and readiness of NPR transcripts whitethorn vary. Transcript matter whitethorn beryllium revised to correct errors aliases lucifer updates to audio. Audio connected npr.org whitethorn beryllium edited aft its original broadcast aliases publication. The charismatic grounds of NPR’s programming is nan audio record.